Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1
Download in electronic PDF format for $75
Abstract: This article (the first in a series), provides an introduction to the use of transdermal medications in veterinary patients. The author discusses the benefits and risks and bioavailability of transdermal gels. She concludes that the ultimate responsibility for the outcome of therapy with transdermally applied drugs rests primarily with the prescribing veterinarian, as well as with the compounding pharmacist. Until data from scientific studies are available, pharmacists and veterinarians must collaborate to evaluate the benefits and risks of transdermal therapy for each patient.
Related Keywords:
pets, transdermal veterinary medication, transdermals for animals, veterinary, veterinary medication, veterinary transdermal medication
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1
Davidson Gigi S
|
Mar/Apr 2001
Pg. 95-96
|
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2
Davidson Gigi S
|
May/Jun 2001
Pg. 214-215
|
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole
Davidson Gigi S
|
Jul/Aug 2001
Pg. 282-283
|
Navigating New Territories in Compounding for Veterinary Medicine
Davidson Gigi S
|
Sep/Oct 2002
Pg. 324-327
|
The Current Landscape of Veterinary Compounding in the Veterinary Setting
Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
|
Sep/Oct 2019
Pg. 428-433
|
When to Compound Medications for Veterinary Patients
Forsythe Lauren Eichstadt
|
Jan/Feb 2017
Pg. 19-21
|
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
|
Jul/Aug 2016
Pg. 271-274
|
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
|
Nov/Dec 2022
Pg. 468-472
|
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R, Davidson Gigi S
|
Sep/Oct 2014
Pg. 366-369
|
Consultation for Human, Veterinary, and Compounded Medications
Moghadam Gabriella, Forsythe Lauren Eichstadt
|
Mar/Apr 2017
Pg. 111-115
|
The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
|
Mar/Apr 2001
Pg. 86-88
|
Book Reviews: Veterinary Compounding
Reed-Kane Dana
|
Mar/Apr 2001
Pg. 108-109
|
Suggested Flavors for Veterinary Medications
Allen Loyd V Jr
|
Jul/Aug 1997
Pg. 228
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
|
Nov/Dec 2016
Pg. 461-467
|
The Current Landscape of Veterinary Compounding in the Pharmacy Setting
Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
|
Sep/Oct 2019
Pg. 422-427
|
United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine
DeVeau Ian
|
Sep/Oct 2007
Pg. 357-362
|
Recommended Tips for Treating Veterinary Patients
Bramwell Bethany L, Williams LaVonn A
|
Sep/Oct 2009
Pg. 390-391
|
Collecting Laboratory and Other Clinical Efficacy Data on Veterinary Patients
Davidson Gigi S, Ashworth Lisa D
|
Sep/Oct 2002
Pg. 384-385
|
A Cross-sectional Online Questionnaire-based Survey About the Use of Compounded Medications in Veterinary Ophthalmology
Andrade Farah de, Saldanha André, Bastos João Thiago, Montiani-Ferreira Fabiano
|
May/Jun 2024
Pg. 214-225
|
| Return to Top |
